You must have the latest - Flash plugin - to view this slideshow. 63-year history of research and clinical excellence

Drug combination delays worsening of disease in women with recurrent ovarian cancer

September 10, 2014

Researchers from the Susan F. Smith Center for Women’s Cancers at Dana-Farber report that for some women with recurrent ovarian cancer, a new drug combination has been found to stall the progression of the disease.

ASCO issues new guideline on treating patients with advanced, HER2-negative breast cancer
September 03, 2014

The American Society of Clinical Oncology (ASCO) today issued a new clinical practice guideline on chemotherapy and targeted therapy for women with HER2-negative advanced breast cancer. The guideline provides detailed, evidenced-based information on the efficacy and side effects of various therapies.

Dana-Farber Cancer Institute receives national certification for highest quality cancer care
September 02, 2014

The Quality Oncology Practice Initiative (QOPI®) Certification Program, an affiliate of the American Society of Clinical Oncology (ASCO), has awarded Dana-Farber Cancer Institute a three-year certification for outpatient hematology-oncology practices that meet its highest standards for quality cancer care.

Early detection and transplantation provide best outcomes for bubble boy disease
July 31, 2014

Children born with so-called “bubble boy” disease have the best chance of survival if they undergo a hematopoietic stem cell transplant as soon after birth as possible, according to a detailed analysis of 10 years published in the New England Journal of Medicine. The researchers say the findings argue for expanding newborn screening for the life-threatening immune disorder.

Drug combination delays worsening of disease in women with recurrent ovarian cancer (Health Canal)

September 11, 2014

A clinical trial led by Dr. Ursula Matulonis and Dr. Joyce Liu showed a two-drug combination can signficantly improve benefit for women with ovarian cancer that has recurred after initial treatment.


PD-L1 Positivity Confers Worse Outcomes in Non–Clear Cell RCC (CancerNetwork)
September 22, 2014

Dr. Toni Choueiri led a study that found patients with non–clear cell renal cell carcinoma, PD-L1 positivity is associated with worse clinical outcomes, including a shorter overall survival and time to recurrence.


Holding your breath for cancer treatment (Portland Tribune)
September 22, 2014

Dr. Jay Harris proposed a breath-holding technique that reduces radiation to the heart during left-sided breast cancer treatment.

Should Women Remove Breasts and Ovaries Because of Future Cancer Risk? (
September 15, 2014

Dr. Harold Burstein commented on a study that found there was no evidence that surgery lowered the risk of death compared to more conservative lumpectomy and radiation.


End-of-life Care Preferences: A Promising Target for Reducing Racial Disparities in Terminal Cancer Care (
September 12, 2014

Shannon Harrington, PhD, participated in a study showing a patient's race and ethnicity dramatically influenced their preferences about the care they receive at the end of their lives.


The Transformation (The New Yorker magazine)
September 11, 2014

Dr. William Kaelin commented on the cancer-stem-cell model, and the possibility of controlling cancer without killing it.


Cancer leaves a common fingerprint on DNA (Oncology Nurse Advisor)
September 10, 2014

Rafael Irizarry, PhD, co-led a new study investigating all stages and types of cancers that appear to share a telltale signature of widespread changes to the epigenome.


Sunset Qigong

September 23, 2014

4:30 PM - 6:00 PM

Smith Room 330, Stoneman Patient Services Suite

Fine tune your mind/body skills and create balance among them. Open to patients and family members. Please register at 617-632-3322. more

Melanoma Support Group(6)

September 23, 2014

5:30 PM - 7:00 PM

Smith 330

This group offers you can opportunity to develop a peer network of shared understanding and support in a setting where you can discuss;

  • Thought, concerns, experiences
  • Communicating with family, friends , co-workers
  • Ways of Coping

Pre-registration is required: To register or for more info: Contact Nancy Bailey at 617-632-3599


Deaconess Medical Center. Call Frank McCaffrey 617 667-3525


Dana-Farber's Mammography Van(41)

September 24, 2014

9:00 AM - 5:30 PM

Joseph Smith Community Health Center - Waltham

Dana-Farber's Mammography Van brings state-of-the-art breast cancer screening to the women of Greater Boston.  To learn more or schedule an appointment, please call 617-632-1974. more

  • Patient referral information, clinical resources and more.

  • Make an Appointment

    For adults:

    For children:

    Or complete the online form.

  • Clinical Trials

    Search current cancer clinical trials at Dana-Farber.

  • How to Help

    Yawkey Center for Cancer Care entrance 

    There are many ways to support Dana-Farber and the Jimmy Fund.

    give now button 
  • Top-ranked

    • U.S. News Best Hospitals Cancer 2014-2015 logo    U.S. News Best Children's Hospitals Cancer 2014-2015 logo 

    Top-ranked cancer center in New England for adults — #1 in the nation for children's cancer

  • Dana-Farber Blog

    Insight Blog screenshot 

    Insight features the latest in cancer care and research news from Dana-Farber.
    Read the blog

  • Dana-Farber eNewsletter

    Dana-Farber Spotlight 

    Stay current on the latest news by signing up for Spotlight, our email newsletter.
    View current issue
    Subscribe now